{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:51:22Z","timestamp":1794412282436,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-14045"],"award-info":[{"award-number":["DISC2-14045"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-14045"],"award-info":[{"award-number":["DISC2-14045"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-14045"],"award-info":[{"award-number":["DISC2-14045"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-14045"],"award-info":[{"award-number":["DISC2-14045"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-14045"],"award-info":[{"award-number":["DISC2-14045"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-14045"],"award-info":[{"award-number":["DISC2-14045"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-14045"],"award-info":[{"award-number":["DISC2-14045"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-14045"],"award-info":[{"award-number":["DISC2-14045"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-14045"],"award-info":[{"award-number":["DISC2-14045"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004322","name":"Agilent Technologies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-025-01523-4","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:02:49Z","timestamp":1762185769000},"page":"1330-1342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A microphysiological system for screening lipid nanoparticle\u2212mRNA complexes predicts in vivo heart transfection efficacy"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1003-1559","authenticated-orcid":false,"given":"Gabriel","family":"Neiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3579-8625","authenticated-orcid":false,"given":"Mauro W.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5545-5238","authenticated-orcid":false,"given":"Hesong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9890-048X","authenticated-orcid":false,"given":"Sheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1338-0025","authenticated-orcid":false,"given":"Tammy","family":"K. Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Siemons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3593-7368","authenticated-orcid":false,"given":"Tomohiro","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"M. Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"R. Conklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3480-5953","authenticated-orcid":false,"given":"Deepak","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7815-7337","authenticated-orcid":false,"given":"Niren","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8524-3671","authenticated-orcid":false,"given":"Kevin E.","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"1523_CR1","doi-asserted-by":"crossref","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789\u20131858 (2018).","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"1523_CR2","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao, C. W. et al. Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association. Circulation 145, e153\u2013e639 (2022).","journal-title":"Circulation"},{"key":"1523_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pathophys.2018.04.003","volume":"25","author":"D Gabriel-Costa","year":"2018","unstructured":"Gabriel-Costa, D. The pathophysiology of myocardial infarction-induced heart failure. Pathophysiology 25, 277\u2013284 (2018).","journal-title":"Pathophysiology"},{"key":"1523_CR4","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese, G. et al. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc. Res. 118, 3272\u20133287 (2023).","journal-title":"Cardiovasc. Res."},{"key":"1523_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2020.10.003","volume":"160","author":"Q Yang","year":"2020","unstructured":"Yang, Q., Fang, J., Lei, Z., Sluijter, J. P. G. & Schiffelers, R. Repairing the heart: State-of the art delivery strategies for biological therapeutics. Adv. Drug Deliv. Rev. 160, 1\u201318 (2020).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1523_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","volume":"23","author":"DE Ingber","year":"2022","unstructured":"Ingber, D. E. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat. Rev. Genet. 23, 467\u2013491 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"1523_CR7","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41592-022-01591-3","volume":"19","author":"S Cho","year":"2022","unstructured":"Cho, S., Discher, D. E., Leong, K. W., Vunjak-Novakovic, G. & Wu, J. C. Challenges and opportunities for the next generation of cardiovascular tissue engineering. Nat. Methods 19, 1064\u20131071 (2022).","journal-title":"Nat. Methods"},{"key":"1523_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1126\/science.adg6276","volume":"379","author":"M Wadman","year":"2023","unstructured":"Wadman, M. FDA no longer has to require animal testing for new drugs. Science 379, 127\u2013128 (2023).","journal-title":"Science"},{"key":"1523_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139587","volume":"10","author":"P Loskill","year":"2015","unstructured":"Loskill, P., Marcus, S. G., Mathur, A., Reese, W. M. & Healy, K. E. muOrgano: a Lego-like plug & play system for modular multi-organ-chips. PLoS ONE 10, e0139587 (2015).","journal-title":"PLoS ONE"},{"key":"1523_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41587-020-0565-5","volume":"38","author":"J van Haasteren","year":"2020","unstructured":"van Haasteren, J., Li, J., Scheideler, O. J., Murthy, N. & Schaffer, D. V. The delivery challenge: fulfilling the promise of therapeutic genome editing. Nat. Biotechnol. 38, 845\u2013855 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1523_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.addr.2011.09.005","volume":"64","author":"HJ Park","year":"2012","unstructured":"Park, H. J., Yang, F. & Cho, S. W. Nonviral delivery of genetic medicine for therapeutic angiogenesis. Adv. Drug Deliv. Rev. 64, 40\u201352 (2012).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1523_CR12","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1021\/acs.nanolett.8b00432","volume":"18","author":"K Paunovska","year":"2018","unstructured":"Paunovska, K. et al. A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation. Nano Lett. 18, 2148\u20132157 (2018).","journal-title":"Nano Lett."},{"key":"1523_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/sj.gt.3302843","volume":"14","author":"H Hatakeyama","year":"2007","unstructured":"Hatakeyama, H. et al. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther. 14, 68\u201377 (2007).","journal-title":"Gene Ther."},{"key":"1523_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","volume":"24","author":"Y Fang","year":"2017","unstructured":"Fang, Y. et al. Cleavable PEGylation: a strategy for overcoming the \u201cPEG dilemma\u201d in efficient drug delivery. Drug Deliv. 24, 22\u201332 (2017).","journal-title":"Drug Deliv."},{"key":"1523_CR15","doi-asserted-by":"publisher","first-page":"e1800917","DOI":"10.1002\/marc.201800917","volume":"40","author":"N Deirram","year":"2019","unstructured":"Deirram, N., Zhang, C., Kermaniyan, S. S., Johnston, A. P. R. & Such, G. K. pH-Responsive polymer nanoparticles for drug delivery. Macromol. Rapid Commun. 40, e1800917 (2019).","journal-title":"Macromol. Rapid Commun."},{"key":"1523_CR16","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1021\/mp100253e","volume":"7","author":"W Gao","year":"2010","unstructured":"Gao, W., Chan, J. M. & Farokhzad, O. C. pH-Responsive nanoparticles for drug delivery. Mol. Pharm. 7, 1913\u20131920 (2010).","journal-title":"Mol. Pharm."},{"key":"1523_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s42003-020-0817-4","volume":"3","author":"L Palanikumar","year":"2020","unstructured":"Palanikumar, L. et al. pH-Responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics. Commun. Biol. 3, 95 (2020).","journal-title":"Commun. Biol."},{"key":"1523_CR18","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/s41565-024-01765-4","volume":"19","author":"S Zhao","year":"2024","unstructured":"Zhao, S. et al. Acid-degradable lipid nanoparticles enhance the delivery of mRNA. Nat. Nanotechnol. 19, 1702\u20131711 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"1523_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep08883","volume":"5","author":"A Mathur","year":"2015","unstructured":"Mathur, A. et al. Human iPSC-based cardiac microphysiological system for drug screening applications. Sci. Rep. 5, 8883 (2015).","journal-title":"Sci. Rep."},{"key":"1523_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35858-7","volume":"8","author":"A Tveito","year":"2018","unstructured":"Tveito, A. et al. Inversion and computational maturation of drug response using human stem cell derived cardiomyocytes in microphysiological systems. Sci. Rep. 8, 17626 (2018).","journal-title":"Sci. Rep."},{"key":"1523_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41551-022-00884-4","volume":"6","author":"N Huebsch","year":"2022","unstructured":"Huebsch, N. et al. Metabolically driven maturation of human-induced-pluripotent-stem-cell-derived cardiac microtissues on microfluidic chips. Nat. Biomed. Eng. 6, 372\u2013388 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"1523_CR22","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1021\/acsptsci.2c00088","volume":"5","author":"V Charwat","year":"2022","unstructured":"Charwat, V. et al. Validating the arrhythmogenic potential of high-, intermediate-, and low-risk drugs in a human-induced pluripotent stem cell-derived cardiac microphysiological system. ACS Pharm. Transl. Sci. 5, 652\u2013667 (2022).","journal-title":"ACS Pharm. Transl. Sci."},{"key":"1523_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/cts.13038","volume":"14","author":"B Charrez","year":"2021","unstructured":"Charrez, B. et al. In vitro safety \u2018clinical trial\u2019 of the cardiac liability of drug polytherapy. Clin. Transl. Sci. 14, 1155\u20131165 (2021).","journal-title":"Clin. Transl. Sci."},{"key":"1523_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.684252","volume":"12","author":"B Charrez","year":"2021","unstructured":"Charrez, B. et al. Heart muscle microphysiological system for cardiac liability prediction of repurposed COVID-19 therapeutics. Front. Pharm. 12, 684252 (2021).","journal-title":"Front. Pharm."},{"key":"1523_CR25","doi-asserted-by":"publisher","first-page":"149ra119","DOI":"10.1126\/scitranslmed.3003594","volume":"4","author":"EA Nance","year":"2012","unstructured":"Nance, E. A. et al. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci. Transl. Med. 4, 149ra119 (2012).","journal-title":"Sci. Transl. Med."},{"key":"1523_CR26","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1529\/biophysj.104.047746","volume":"87","author":"JK Armstrong","year":"2004","unstructured":"Armstrong, J. K., Wenby, R. B., Meiselman, H. J. & Fisher, T. C. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys. J. 87, 4259\u20134270 (2004).","journal-title":"Biophys. J."},{"key":"1523_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133\u2013140 (2010).","journal-title":"Nat. Neurosci."},{"key":"1523_CR28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.stem.2020.05.004","volume":"26","author":"E Giacomelli","year":"2020","unstructured":"Giacomelli, E. et al. Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease. Cell Stem Cell 26, 862\u2013879.e11 (2020).","journal-title":"Cell Stem Cell"},{"key":"1523_CR29","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1016\/j.biomaterials.2010.05.027","volume":"31","author":"R Kedmi","year":"2010","unstructured":"Kedmi, R., Ben-Arie, N. & Peer, D. The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation. Biomaterials 31, 6867\u20136875 (2010).","journal-title":"Biomaterials"},{"key":"1523_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40360-018-0230-5","volume":"19","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Cationic liposomes induce cytotoxicity in HepG2 via regulation of lipid metabolism based on whole-transcriptome sequencing analysis. BMC Pharm. Toxicol. 19, 43 (2018).","journal-title":"BMC Pharm. Toxicol."},{"key":"1523_CR31","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/ani9100754","volume":"9","author":"RC Hubrecht","year":"2019","unstructured":"Hubrecht, R.C. & Carter, E. The 3Rs and humane experimental technique: implementing change. Animals 9, 754 (2019).","journal-title":"Animals"},{"key":"1523_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep24726","volume":"6","author":"N Huebsch","year":"2016","unstructured":"Huebsch, N. et al. Miniaturized iPS-cell-derived cardiac muscles for physiologically relevant drug response analyses. Sci. Rep. 6, 24726 (2016).","journal-title":"Sci. Rep."},{"key":"1523_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2022.01.027","volume":"343","author":"MJW Evers","year":"2022","unstructured":"Evers, M. J. W. et al. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles. J. Control. Release 343, 207\u2013216 (2022).","journal-title":"J. Control. Release"},{"key":"1523_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cell.2018.02.014","volume":"173","author":"TMA Mohamed","year":"2018","unstructured":"Mohamed, T. M. A. et al. Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell 173, 104\u2013116.e112 (2018).","journal-title":"Cell"},{"key":"1523_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCRESAHA.123.322929","volume":"133","author":"J Sun","year":"2023","unstructured":"Sun, J. et al. CCND2 modified mRNA activates cell cycle of cardiomyocytes in hearts with myocardial infarction in mice and Pigs. Circ. Res. 133, 484\u2013504 (2023).","journal-title":"Circ. Res."},{"key":"1523_CR36","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1161\/CIRCRESAHA.112.300625","volume":"113","author":"L Qian","year":"2013","unstructured":"Qian, L. & Srivastava, D. Direct cardiac reprogramming: from developmental biology to cardiac regeneration. Circ. Res. 113, 915\u2013921 (2013).","journal-title":"Circ. Res."},{"key":"1523_CR37","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/nbt.2682","volume":"31","author":"L Zangi","year":"2013","unstructured":"Zangi, L. et al. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat. Biotechnol. 31, 898\u2013907 (2013).","journal-title":"Nat. Biotechnol."},{"key":"1523_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1674-8301(10)60023-1","volume":"24","author":"W Qin","year":"2010","unstructured":"Qin, W., Chen, X. & Liu, P. Inhibition of TGF-\u03b21 by eNOS gene transfer provides cardiac protection after myocardial infarction. J. Biomed. Res. 24, 145\u2013152 (2010).","journal-title":"J. Biomed. Res."},{"key":"1523_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s10544-020-0469-7","volume":"22","author":"Y Jiao","year":"2020","unstructured":"Jiao, Y. et al. Research progress of nucleic acid delivery vectors for gene therapy. Biomed. Microdevices 22, 16 (2020).","journal-title":"Biomed. Microdevices"},{"key":"1523_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/cpcb.51","volume":"79","author":"MS Fernandopulle","year":"2018","unstructured":"Fernandopulle, M. S. et al. Transcription factor-mediated differentiation of human iPSCs into neurons. Curr. Protoc. Cell Biol. 79, e51 (2018).","journal-title":"Curr. Protoc. Cell Biol."},{"key":"1523_CR41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.4490","volume":"24","author":"Y Shi","year":"2018","unstructured":"Shi, Y. et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS\/FTD human induced motor neurons. Nat. Med. 24, 313\u2013325 (2018).","journal-title":"Nat. Med."},{"key":"1523_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuron.2019.07.014","volume":"104","author":"R Tian","year":"2019","unstructured":"Tian, R. et al. CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons. Neuron 104, 239\u2013255.e212 (2019).","journal-title":"Neuron"},{"key":"1523_CR43","doi-asserted-by":"publisher","first-page":"e0116032","DOI":"10.1371\/journal.pone.0116032","volume":"10","author":"CR Trevor","year":"2015","unstructured":"Trevor, C. R. et al. Transcription activator-like effector nuclease (TALEN)-mediated CLYBL targeting enables enhanced transgene expression and one-step generation of dual reporter human induced pluripotent stem cell (iPSC) and neural stem cell (NSC) lines. PLoS ONE 10, e0116032 (2015).","journal-title":"PLoS ONE"},{"key":"1523_CR44","doi-asserted-by":"publisher","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","volume":"109","author":"X Lian","year":"2012","unstructured":"Lian, X. et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl Acad. Sci. USA 109, E1848\u2013E1857 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1523_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/7651_2020_300","volume":"2454","author":"H Zhang","year":"2022","unstructured":"Zhang, H., Shen, M. & Wu, J. C. Generation of quiescent cardiac fibroblasts derived from human induced pluripotent stem cells. Methods Mol. Biol. 2454, 109\u2013115 (2022).","journal-title":"Methods Mol. Biol."},{"key":"1523_CR46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","volume":"18","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nat. Protoc. 18, 265\u2013291 (2023).","journal-title":"Nat. Protoc."},{"key":"1523_CR47","doi-asserted-by":"publisher","first-page":"10767","DOI":"10.1021\/jacs.5b06644","volume":"137","author":"YL Huang","year":"2015","unstructured":"Huang, Y. L., Walker, A. S. & Miller, E. W. A photostable silicon rhodamine platform for optical voltage sensing. J. Am. Chem. Soc. 137, 10767\u201310776 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"1523_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cell.2018.02.014","volume":"173","author":"MA Tamer","year":"2018","unstructured":"Tamer, M. A. et al. Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell 173, 104\u2013116.e12 (2018).","journal-title":"Cell"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01523-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01523-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01523-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:03:55Z","timestamp":1784239435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01523-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1523"],"URL":"https:\/\/doi.org\/10.1038\/s41551-025-01523-4","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"28 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.E.H. and B.S. have a financial relationship with Organos Inc., and hence may benefit from the commercialization of the results of this research. N.M. and H.H. have a financial relationship in Opus Biosciences, and may benefit from the commercialization of the results of this research. D.S. is a scientific co-founder, shareholder and director of Tenaya Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}